SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TXB -Texas Biotechnology -- Ignore unavailable to you. Want to Upgrade?


To: DZOO who wrote (14)12/29/1997 6:41:00 PM
From: Dave Yenne  Read Replies (1) | Respond to of 19
 
Nice jump in the share price today, up 1/4. TXB is having an investors conference in February. If we hear good news out of the conference, we could see a good positive bump in the share price. Paine Webber has a price target of $12-14/share in the next 12-14 months.

Does anyone know what the testing order is for FDA approval of a new drug or treatment? TXB has a couple in Phase II testing. Is there a phase III and so on?

Dave....